ROS Imaging Agent Mitochondrial Trapping for Neurodegenerative Disease Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiotracers are inadequate for non-invasively detecting reactive oxygen species (ROS) in vivo, particularly in the brain, which is crucial for diagnosing and monitoring neurodegenerative diseases like Alzheimer's and Parkinson's, as they poorly correlate with oxidative imbalance and lack specificity and sensitivity.
Innovation Solution
Development of heterocyclic, highly fluorescent small organic molecules, such as 18F-SLN-128, that penetrate neuronal cells, get oxidized by ROS, and become trapped within mitochondria, allowing for PET/CT imaging of ROS generation and distribution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current radiotracers are used for detecting ROS in vivo, then imaging can be performed, but the detection sensitivity and specificity are inadequate
Solution Approach 1:
The patent modifies molecular parameters by incorporating heterocyclic structures with specific functional groups (nitro, azido, nitrile) that are highly sensitive to oxidation by ROS. These parameter changes in molecular structure enable the tracer to undergo measurable transformation upon ROS exposure, significantly improving detection sensitivity and specificity while maintaining reliable correlation with oxidative imbalance in neurodegenerative diseases
Solution Approach 2:
The imaging agent combines multiple functional components into a composite molecule: a heterocyclic core structure, oxidizable functional groups (nitro, azido, or nitrile), and a radiolabel (such as 18F). This composite design integrates the benefits of ROS sensitivity, imaging capability, and molecular stability, resolving the contradiction between detection precision and reliability by ensuring both high sensitivity to ROS and accurate reflection of oxidative stress in vivo
2Measurement precision
If heterocyclic fluorescent molecules are developed to penetrate neuronal cells and be trapped by ROS, then sensitivity and specificity are enhanced, but the complexity of the imaging agent increases
Solution Approach 1:
The imaging agent is segmented into distinct functional modules: a heterocyclic core (providing fluorescence and ROS sensitivity), oxidizable functional groups (nitro, azido, or nitrile for ROS interaction), and a radiolabel attachment point. This segmentation allows each component to perform its specific function while maintaining overall molecular manageability, achieving high sensitivity and specificity without excessive complexity
Solution Approach 2:
The heterocyclic core structure serves multiple functions simultaneously: it provides the fluorescent signal, enables ROS detection through oxidation of the functional groups, and facilitates cellular penetration. This multi-functionality reduces the need for additional separate components, thereby enhancing sensitivity and specificity while controlling molecular complexity
3Measurement precision
If the imaging agent is designed to be trapped within mitochondria upon oxidation, then ROS detection accuracy improves, but the device complexity and synthesis difficulty increase
Solution Approach 1:
The imaging agent utilizes the body's own oxidative environment to trigger its trapping mechanism. Upon encountering ROS in mitochondria, the functional groups (nitro, azido, or nitrile) are automatically oxidized, causing the molecule to become trapped within the mitochondria. This self-service mechanism eliminates the need for complex external triggering systems or sophisticated synthesis pathways, improving ROS detection accuracy while maintaining ease of manufacture
Solution Approach 2:
The patent employs parameter changes in the oxidation state of the functional groups (nitro, azido, or nitrile) to control mitochondrial trapping. The oxidation of these groups by ROS alters the molecule's charge and hydrophobicity, enabling passive accumulation in mitochondria. This approach achieves high ROS detection accuracy through a simple chemical transformation that can be incorporated into existing synthetic pathways, avoiding excessive synthesis complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables non-invasive, quantitative imaging of ROS in the brain and other tissues, providing early diagnosis and monitoring of neurodegenerative diseases, with enhanced sensitivity and specificity compared to existing tracers, and potential applications beyond Alzheimer's disease.
Implementation Method 1
get oxidized by ROS, and become trapped within mitochondria
Implementation Method 2
ROS imaging agent comprises a radiolabel or radionuclide... allowing for PET/CT imaging of ROS generation and distribution
Data Source
AI summary
The present disclosure provides compositions and methods for reactive oxygen species imaging agents. Compositions include a reactive oxygen species (ROS) imaging agent according to any one of Formulas (I-VI)a and (I-VII)b. Methods of detecting ROS in a subject include administering to the subject an effective amount of a composition comprising a reactive oxygen species (ROS) imaging agent according to any one of Formulas (I-VI)a and (I-VII)b, and exposing the subject to an imaging modality such as PET or CT. Administering the composition comprising the ROS imaging agent results in penetration of the ROS imaging agent into a membrane, oxidation of the ROS imaging 10 agent by ROS, and trapping of the ROS imaging agent in a cell membrane and intracellular compartments.